# EDGAR Filing Document

**Accession Number:** 0001231457
**File Stem:** 0001193125-23-013082
**Filing Date:** 2023-1
**Character Count:** 2485
**Document Hash:** 16756fbcd665662f51822cbcd09c7228
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-013082.hdr.sgml**: 20230223

**ACCESSION NUMBER**: 0001193125-23-013082

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230123

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GENELUX CORP
- **CENTRAL INDEX KEY:** 0001231457
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1177 IDAHO STREET
- **CITY:** REDLANDS
- **STATE:** CA
- **ZIP:** 92374
- **BUSINESS PHONE:** 858-483-0024

**MAIL ADDRESS:**
- **STREET 1:** 1177 IDAHO STREET
- **CITY:** REDLANDS
- **STATE:** CA
- **ZIP:** 92374

January 23, 2023

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Genelux Corporation**  |

---

**Registration Statement on Form S-1** 

**File No. 333-265828** 

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the "Securities Act"), The Benchmark Company LLC, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 4:00 p.m. Eastern Time on January 25, 2023 or as soon thereafter as practicable.

Pursuant to Rule 460 under the Securities Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus to underwriters, dealers, institutions, and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating underwriters that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.

[Signature Page Follows]

------

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| THE BENCHMARK COMPANY LLC | THE BENCHMARK COMPANY LLC |
| By: | /s/ Michael Jacobs |
| Name: Michael Jacobs | Name: Michael Jacobs |
| Title: Head of Equity Capital Markets | Title: Head of Equity Capital Markets |

---

[Signature Page to Acceleration Request]